Is BMY Stock A Sell After Panel Recommends FDA Revoke An Opdivo Approval?

An independent panel recommended the Food and Drug Administration revoke approval for Opdivo as a second option for liver cancer patients. Is Bristol Myers Squibb stock a sell?
Read More